Actively Recruiting
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
Led by Shandong University · Updated on 2024-12-02
300
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
Sponsors
S
Shandong University
Lead Sponsor
S
Shandong Public Health Clinical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.
CONDITIONS
Official Title
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy.
You will not qualify if you...
- Pregnant or lactating women.
- Other factors deemed unsuitable by the researchers.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shandong Public Health Clinical Center
Jinan, China
Actively Recruiting
Research Team
W
Wei Zhao, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here